Aging Modifies the Effect of GCH1 RS11158026 on DAT Uptake and Parkinson's Disease Clinical Severity

Neurobiology of Aging - United States
doi 10.1016/j.neurobiolaging.2016.10.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Degree of Parkinson's Disease Severity Estimation Based on Speech Signal Processing

2016English

Neuromelanin or DaT‐ SPECT : Which Is the Better Marker for Discriminating Advanced Parkinson's Disease?

European Journal of Neurology
Neurology
2019English

Fully Automated Assessment of the Severity of Parkinson's Disease From Speech

Computer Speech and Language
Theoretical Computer ScienceHuman-Computer InteractionSoftware
2015English

Brain Mitochondrial Dysfunction in Aging, Neurodegeneration and Parkinson's Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2010English

Parkinson's Disease Severity and Motor Subtype Influence Physical Capacity Components

Motriz. Revista de Educacao Fisica
MedicineHealthSports Science
2013English

Effect of Levodopa on Speech Dysfluency in Parkinson's Disease

Movement Disorders Clinical Practice
Neurology
2018English

Effect of Social Class on the Prevalence and Severity of Periodontal Disease

Annals of Ibadan Postgraduate Medicine
2011English

The Effect of Medication and Deep Brain Stimulation on Posture in Parkinson's Disease

Frontiers in Neurology
Neurology
2019English

The Effect of Manganese on Dopamine Toxicity and Dopamine Transporter (DAT) in Control and DAT Transfected HEK Cells

NeuroToxicology
ToxicologyNeuroscience
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy